$300 | Single User
$600 | Site License
$900 | Global License

Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017]

Published by Global Data: 13 Nov 2017 | 144620 | In Stock

Introduction

Summary

Yuyu Pharma Inc (Yuyu), formerly YuYu Industrial Co develops and markets medicines in various fields such as osteoporosis, stroke, and dementia. The company's products include prescription, non prescription, quasi drugs and health supplements. Its prescription drugs include osteoporosis drugs, brainbone metabolism-hypocalcemia improvement drugs, cerebral and peripheral circulatory disturbance drugs, respiratory organ drugs, hypertension drugs, tromboembolism drugs, other circulatory system drugs, hyperlipidemia drugs, pulmonary tuberculosis therapy drugs, migraine drugs, diabetic neuropathy therapy drugs, urinary system(organ) drugs, eczematous dermatitis drugs, antibiotics and others,. The company has its presence across South Korea. Yuyu is headquartered in Seoul, South Korea.

This comprehensive SWOT profile of Yuyu Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Yuyu Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017]

  • Table of Contents

    Section 1 - About the Company

    Yuyu Pharma Inc - Key Information

    Yuyu Pharma Inc - Overview

    Yuyu Pharma Inc - Key Employees

    Yuyu Pharma Inc - Key Employee Biographies

    Yuyu Pharma Inc - Key Operational Heads

    Yuyu Pharma Inc - Major Products and Services

    Yuyu Pharma Inc - History

    Yuyu Pharma Inc - Company Statement

    Yuyu Pharma Inc - Locations And Subsidiaries

    Yuyu Pharma Inc - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Yuyu Pharma Inc - Business Description

    Yuyu Pharma Inc - Corporate Strategy

    Yuyu Pharma Inc - SWOT Analysis

    SWOT Analysis - Overview

    Yuyu Pharma Inc - Strengths

    Yuyu Pharma Inc - Weaknesses

    Yuyu Pharma Inc - Opportunities

    Yuyu Pharma Inc - Threats

    Yuyu Pharma Inc - Key Competitors

    Section 3 - Company Financial Performance Charts

    Yuyu Pharma Inc - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017]

List of Tables


Yuyu Pharma Inc, Key Information

Yuyu Pharma Inc, Key Ratios

Yuyu Pharma Inc, Share Data

Yuyu Pharma Inc, Major Products and Services

Yuyu Pharma Inc, History

Yuyu Pharma Inc, Key Employees

Yuyu Pharma Inc, Key Employee Biographies

Yuyu Pharma Inc, Key Operational Heads

Yuyu Pharma Inc, Other Locations

Yuyu Pharma Inc, Subsidiaries

Yuyu Pharma Inc, Key Manufacturing facilities

Yuyu Pharma Inc, Key Competitors

Yuyu Pharma Inc, SWOT Analysis

Yuyu Pharma Inc, Ratios based on current share price

Yuyu Pharma Inc, Annual Ratios

Yuyu Pharma Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017]

List of Figures


Yuyu Pharma Inc, Performance Chart

Yuyu Pharma Inc, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

144620 | GDPH79853FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review
SummaryYuyu Pharma Inc (Yuyu), formerly YuYu Industrial Co develops and markets medicines in various...
07 Aug 2017 by Global Data USD $300 More Info
Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review
SummaryYuyu Pharma Inc (Yuyu), formerly YuYu Industrial Co develops and markets medicines in various...
15 May 2017 by Global Data USD $300 More Info
Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review
SummaryYuyu Pharma Inc (Yuyu), formerly YuYu Industrial Co develops and markets medicines in various...
13 Jan 2017 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Yuyu Pharma Inc (000220) - Financial and Strategic SWOT Analysis Review [Report Updated: 13-11-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data